Ispectamab

• Description :

  Ispectamab is an anti-TNFRSF17 human IgG1 κ monoclonal antibody[1]. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001) .

• UNSPSC :

  12352203

• Hazard Statement :

  H302, H315, H319, H335

• Target :

  TNF Receptor

• Type :

  Inhibitory Antibodies

• Related Pathways :

  Apoptosis

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/ispectamab.html

• Purity :

  98.102

• Molecular Weight :

  (146.104 kDa)

• Precautions :

  H302, H315, H319, H335

• References & Citations :

  [1]Ispectamab

• Shipping Conditions :

  Dry Ice

• Storage Conditions :

  -80°C

• Scientific Category :

  Inhibitory Antibodies

• Clinical Information :

  No Development Reported